ratio as the first line test in the investigation of suspected phaeochromocytoma. Specimens with HMMA/HVA ratio greater than 2'4 are then followed up by measurement of NMET and MET (and/or noradrenaline and adrenaline) .
An additional advantage of measuring HV A in combination with HMMA is in the presence of a dopamine-secreting tumour, when HV A is likely to be raised. This would probably be missed unless either dopamine itself, or the intermediate metabolite 3-methoxytyramine was measured.
Finally, Roberts et al. 5 have recently reported a case of an adrenaline-secreting ganglioneuroblastoma in which a marked increase in urinary HMMA was accompanied by normal excretion of total metanephrines. I therefore believe that there is still a place for the measurement of urinary HMMA in the investigation of possible catecholamine-secreting tumours, and that the HMMA/HVA ratio is a sensitive and relatively specific first line test in the investigation of possible phaeochromocytoma. 
Authors' reply
We currently measure 24 h urinary noradrenaline, adrenaline, normetanephrine and metanephrine on all requests for phaeochromocytoma investi-
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gations and find this profile to be the most effective in detecting phaeochromocytoma. Dopamine is also measured, but we have yet to see a dopamine secreting phaeochromocytoma. Current methods for metanephrines are technically demanding and HMMA/HVA screening would be less expensive, but the purpose of screening for phaeochromocytoma is to detect all tumours.
A preliminary review of our data does not show 1000/0 sensitivity using a cut-off of 2'4 for HMMA/HVA ratio. We have at least four proven cases of phaeochromocytomas which had HMMA/HVA ratios of I· 2, 1'7, 1·0 and I· 8. Two of these patients had normal HMMAs (20 ",mol/L and 32 ",mol/L).
P E GRAHAM, G S SMYTHE G A EDWARDS AND L LAZARUS
Department of Chemical Pathology, St Vincent's Hospital, Darlinghurst NSW 2010, Australia
Mononuclear blood cell magnesium
A recent paper by Martin et al. assessed the clinical usefulness of measuring mononuclear cell (MBC) magnesium content in ill, hospitalized patients. I The authors noted a tendency, although reported as non-significant, for the MBC magnesium content (fmol/cell) to be higher in ill patients than the healthy community controls. However, from the data given in their Table 2 the difference between these two groups appears highly significant (P<0'05, d.f. =43). This would support our observations in that ill patients appear to have a considerably raised MBC magnesium content. Examination of the cells harvested by this Ficoll-Paque gradient separation technique from ill patients reveals the presence of a left shift in the white cell profile, presumably a reflection of the stress response. Given that reticulocytes contain eight times as much magnesium as mature red cells it is highly likely that the presence of early white cells will increase the average magnesium content of the MBC layer. Consequently, comparing these results to the MBC content of the mature cell population in healthy controls could lead to spurious conclusions.
In addition, the authors noted a considerable variation in multiple measurements from the Ann Clin Biochem 1993: 30 
